Advertisement
Nasri during his time at Man City. Zuma Press/PA Images
free agent

Samir Nasri set to sign for West Ham as doping ban nears end

The Frenchman has reportedly undergone a medical and he will be available to play from 1 January.

SAMIR NASRI IS in line to rejoin Manuel Pellegrini at West Ham when his doping suspension ends.

A number of media outlets, including The Evening Standard, are reporting the 31-year-old midfielder, who played under Pellegrini at Manchester City, has undergone a medical prior to signing a short-term contract with London club West Ham.

While the former France international’s ban means he is unable to play until 1 January, the terms of Nasri’s suspension allow him to train with any club from this month onwards.

In February, Nasri was given a six-month suspension after taking a multi-vitamin booster in contravention of World Anti-Doping Agency (Wada) rules.

Nasri had the drip treatment at a Los Angeles clinic two years ago while he was on loan at Sevilla from City during the 2016/17 season, prompting the Spanish anti-doping agency to open an investigation.

He retroactively appealed to Uefa to grant him a therapeutic use exemption (TUE), but his request was refused by European football’s governing body.

August saw Uefa extend Nasri’s doping ban from six to 18 months, his suspension backdated to July 1, 2017 although he has played since then.

Nasri, who made his name in England with West Ham’s London rivals Arsenal after joining from Marseille, left Turkish side Antalya in January after a disappointing six-month spell following his arrival from City.

© AFP 2018

Subscribe to our new podcast, Heineken Rugby Weekly on The42, here:

Your Voice
Readers Comments
7
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel